# New York State Contract Reporter #2140115

Three-year administration of the NeuroCatalyst Commercialization Fund

**Posted:** October 21, 2026
**Respond By:** November 18, 2026
**Identifier:** 2140115
**NAICS:** 541715, 926110

Empire State Development is seeking a third-party administrator for its $45 million NeuroCatalyst Commercialization Fund, which supports commercialization of life-science innovations addressing neurodegenerative diseases.
- **Government buyer:** Empire State Development (ESD), with the opportunity associated with its Contract Administration division and Life Science Initiative.
- **Requested service:** A qualified firm to implement and administer the Fund over a three-year term, supporting multiple anticipated annual application cycles.
- **Key responsibilities:**
  - Develop, host, distribute, receive, process, and manage applications; screen eligibility and support cloud-based application evaluation.
  - Conduct applicant and awardee outreach, information sessions, marketing, and communications.
  - Recruit and coordinate expert reviewers and mentors; manage review, scoring, and synthesis of reviewer feedback; provide an as-needed mentor program.
  - Provide commercialization assistance, coordinate Advisory Committee communications and meetings, and manage grantee information collection.
  - Develop and maintain the Fund website or web content, and provide deliverables and reporting.
- **Fund focus:** New York life-science research and innovations for neurodegenerative diseases, supporting efforts from academic translation through venture financing.
- **Participation goals:** 6% SDVOB, 15% MBE, and 15% WBE.
- **Notable requirements:** Applicable information-security standards and requirements include ISO 27001, ISO 27005, ISO 27035, relevant New York State and federal cybersecurity requirements, and GDPR where applicable.
- **OEMs and named vendors:** No OEMs, product vendors, or specific products are identified. No hardware, part numbers, or purchase quantities are requested.
- **Contract value:** The $45 million figure is the Fund amount, not a stated value for the administrator contract; the contract value is not provided.

### Description

Empire State Development intends to establish a $45 million NeuroCatalyst Commercialization Fund to accelerate development and commercialization of life science research and innovations addressing neurodegenerative diseases. The agency seeks a qualified third-party firm to help implement and administer the Fund. Services include managing application development, distribution, and processing; conducting information sessions and outreach; arranging an as-needed mentor program; identifying and managing expert reviewers and mentors; and supporting marketing, website content, and stakeholder communications. The contract term is three years.

[View original listing](https://www.nyscr.ny.gov/Ads/Search)